Since it is generally thought that these pro-inflammatory compounds and insulin-resistance inducing substances originate from the adipose tissue and the liver [2, 4, 32, 33], we assume that also HGF in the serum of the patients with T2D primarily stems from these sources. The gene discussed is HGF; the disease is type 2 diabetes mellitus.